MOORE CAPITAL MANAGEMENT, LP
Position in TSHA — Taysha Gene Therapies, Inc.
CIK 1448574
NEW YORK, NY
Position in TSHA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,440,526
+$970,652 QoQ
Shares Held
358,374
+9.0% QoQ
Ownership
0.110%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#67
of 208 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TSHA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MOORE CAPITAL MANAGEMENT, LP holds $125,911,351 across 33 Biotechnology names. TSHA ranks #18 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
81,700 | $15,300,776 | |
| 2 | GMAB |
Genmab A/S
|
420,487 | $11,550,777 | |
| 3 | TECH |
BIO-TECHNE Corp
|
125,626 | $8,875,476 | |
| 4 | IMCR |
Immunocore Holdings plc
|
274,663 | $8,720,550 | |
| 5 | RLAY |
Relay Therapeutics, Inc.
|
414,005 | $7,746,033 | |
| 6 | DYN |
Dyne Therapeutics, Inc.
|
305,794 | $6,791,684 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
75,588 | $6,165,713 | |
| 8 | SLDB |
Solid Biosciences Inc.
|
603,472 | $6,028,685 |
All Filings in TSHA
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,440,526 | 358,374 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,469,874 | 328,831 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||